LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 50.36 | 84.90 | 1020 | 5651 | 0.1805 | 0.5075 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.06 | 84.90 | 839 | 5990 | 0.1401 | 0.4521 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.06 | 84.90 | 858 | 5990 | 0.1432 | 0.4574 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.06 | 84.90 | 32 | 5990 | 0.0053 | -0.1469 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 52.06 | 84.90 | 1080 | 5990 | 0.1803 | 0.5131 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.77 | 84.90 | 914 | 6252 | 0.1462 | 0.4669 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.77 | 84.90 | 936 | 6252 | 0.1497 | 0.4725 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.77 | 84.90 | 38 | 6252 | 0.0061 | -0.1216 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.77 | 84.90 | 1041 | 6252 | 0.1665 | 0.4980 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 55.48 | 84.90 | 894 | 6567 | 0.1361 | 0.4554 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 55.48 | 84.90 | 915 | 6567 | 0.1393 | 0.4608 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 55.48 | 84.90 | 36 | 6567 | 0.0055 | -0.1278 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 55.48 | 84.90 | 1047 | 6567 | 0.1594 | 0.4925 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 57.18 | 84.90 | 893 | 6963 | 0.1282 | 0.4479 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 57.18 | 84.90 | 924 | 6963 | 0.1327 | 0.4557 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 57.18 | 84.90 | 42 | 6963 | 0.0060 | -0.1048 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 57.18 | 84.90 | 1024 | 6963 | 0.1471 | 0.4794 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.88 | 84.90 | 923 | 7291 | 0.1266 | 0.4498 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.88 | 84.90 | 949 | 7291 | 0.1301 | 0.4561 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.88 | 84.90 | 33 | 7291 | 0.0045 | -0.1368 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.88 | 84.90 | 1054 | 7291 | 0.1445 | 0.4801 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.59 | 84.90 | 881 | 7641 | 0.1153 | 0.4339 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.59 | 84.90 | 910 | 7641 | 0.1191 | 0.4411 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.59 | 84.90 | 45 | 7641 | 0.0059 | -0.0931 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.59 | 84.90 | 1105 | 7641 | 0.1446 | 0.4848 | MN20160318_Q02 | G16 |